Randy L Jensen

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi Cauda equina syndrome as a postoperative complication of lumbar spine surgery
    Randy L Jensen
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132, USA
    Neurosurg Focus 16:e7. 2004
  2. ncbi Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development
    Peter Kan
    Department of Neurosurgery, University of Utah Health Sciences Center, 175 N Medical Drive East, Salt Lake City, UT 84132, USA
    J Neurooncol 83:33-8. 2007
  3. ncbi Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo
    David L Gillespie
    Department of Neurosurgery, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA
    Methods Mol Biol 487:283-301. 2009
  4. ncbi Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo
    David L Gillespie
    Department of Neurosurgery, Huntsman Cancer Institute in the Division of Pediatric Hematology Oncology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Clin Cancer Res 13:2441-8. 2007
  5. ncbi Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme
    Jeannette R Flynn
    Center for Children, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
    Cancer 113:1032-42. 2008
  6. ncbi Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro
    Brian T Ragel
    Department of Neurosurgery, University of Utah, 30 North 1900 East, Suite 3B409, Salt Lake City, UT 84132, USA
    Neurosurgery 59:1109-20; discussion 1120-1. 2006
  7. ncbi Celecoxib inhibits meningioma tumor growth in a mouse xenograft model
    Brian T Ragel
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132, USA
    Cancer 109:588-97. 2007
  8. ncbi A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results
    Matthias C Schabel
    Utah Center for Advanced Imaging Research, Department of Radiology, University of Utah Health Sciences Center, 729 Arapeen Drive, Salt Lake City, UT 84108 1218, USA
    Phys Med Biol 55:4807-23. 2010
  9. ncbi Transient postictal MRI changes in patients with brain tumors may mimic disease progression
    Michael A Finn
    Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, UT 84132 2303, USA
    Surg Neurol 67:246-50; discussion 250. 2007
  10. ncbi Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS)
    Wolfram E Samlowski
    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA
    Cancer 109:1855-62. 2007

Collaborators

Detail Information

Publications45

  1. ncbi Cauda equina syndrome as a postoperative complication of lumbar spine surgery
    Randy L Jensen
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132, USA
    Neurosurg Focus 16:e7. 2004
    ..In this study the author describes two cases of CES that occurred following uneventful lumbar spine procedures--one microdiscectomy and one decompressive laminectomy...
  2. ncbi Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development
    Peter Kan
    Department of Neurosurgery, University of Utah Health Sciences Center, 175 N Medical Drive East, Salt Lake City, UT 84132, USA
    J Neurooncol 83:33-8. 2007
    ..Although uncommon, peritumoral edema can develop as a delayed complication after SRS. The purpose of the study was to evaluate the clinical and molecular risk factors for peritumoral edema after SRS for intracranial meningiomas...
  3. ncbi Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo
    David L Gillespie
    Department of Neurosurgery, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA
    Methods Mol Biol 487:283-301. 2009
    ..Here we present methods for investigating the role of HIF-1alpha in glioma growth in vivo and in vitro using RNA interference in U251, U87, and U373 glioma cells...
  4. ncbi Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo
    David L Gillespie
    Department of Neurosurgery, Huntsman Cancer Institute in the Division of Pediatric Hematology Oncology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Clin Cancer Res 13:2441-8. 2007
    ..Hypoxia inducible factor-1alpha (HIF-1alpha) is a main responder to intracellular hypoxia and is overexpressed in many human cancers, including gliomas...
  5. ncbi Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme
    Jeannette R Flynn
    Center for Children, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
    Cancer 113:1032-42. 2008
    ....
  6. ncbi Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro
    Brian T Ragel
    Department of Neurosurgery, University of Utah, 30 North 1900 East, Suite 3B409, Salt Lake City, UT 84132, USA
    Neurosurgery 59:1109-20; discussion 1120-1. 2006
    ..These results suggest a possible role for these drugs as an additional adjuvant therapy for recurrent or unresectable meningiomas...
  7. ncbi Celecoxib inhibits meningioma tumor growth in a mouse xenograft model
    Brian T Ragel
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132, USA
    Cancer 109:588-97. 2007
    ..We therefore tested the effects of celecoxib on meningioma growth in a mouse xenograft model...
  8. ncbi A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results
    Matthias C Schabel
    Utah Center for Advanced Imaging Research, Department of Radiology, University of Utah Health Sciences Center, 729 Arapeen Drive, Salt Lake City, UT 84108 1218, USA
    Phys Med Biol 55:4807-23. 2010
    ..These results demonstrate that the MCBE algorithm is a useful alternative to direct AIF measurement in cases where acquisition of high-quality arterial input function data is difficult or impossible...
  9. ncbi Transient postictal MRI changes in patients with brain tumors may mimic disease progression
    Michael A Finn
    Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, UT 84132 2303, USA
    Surg Neurol 67:246-50; discussion 250. 2007
    ..Interval changes on repeat imaging can mimic disease progression or other pathologic processes...
  10. ncbi Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS)
    Wolfram E Samlowski
    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA
    Cancer 109:1855-62. 2007
    ..We performed a retrospective analysis of our institutional experience of multimodality treatment utilizing linear accelerator (Linac)-based stereotactic radiosurgery (SRS)...
  11. ncbi Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme
    Christopher J Anker
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah School of Medicine, 1950 Circle of Hope, Rm 1570, Salt Lake City, UT, 581 2396, USA
    J Neurooncol 98:253-63. 2010
    ..It is possible inclusion of such patients in a series of SRS for GBM could mask a benefit in remaining patients. No significant difference in OS or PFS based on SRS-eligibility status was found...
  12. ncbi Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases
    Martin Majer
    Multidisciplinary Melanoma Program, Huntsman Cancer Institute, Salt Lake City, Utah, USA
    Cancer 110:1329-37. 2007
    ....
  13. ncbi Overall and progression-free survival and visual and endocrine outcomes for patients with parasellar lesions treated with intensity-modulated stereotactic radiosurgery
    Randy L Jensen
    Department of Neurosurgery, Huntsman Cancer Institute, University of Utah Health Sciences Center, 5th Floor, Clinical Neurosciences Center, 175 North Medical Drive, Salt Lake City, UT, 84132, USA
    J Neurooncol 98:221-31. 2010
    ....
  14. ncbi Novalis intensity-modulated radiosurgery: methods for pretreatment planning
    Randy L Jensen
    Department of Neurosurgery, The Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah, USA
    Neurosurgery 62:A2-9; discussion A9-10. 2008
    ..We describe our methods and results of preprocedure planning for IMRS for patients with lesions in the cavernous sinus or parasellar regions in whom the dose to the optic nerve or chiasm might exceed our acceptable tolerance dose (8 Gy)...
  15. ncbi Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimator
    Lisa J Hazard
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah School of Medicine, Salt Lake City, UT, USA
    Int J Radiat Oncol Biol Phys 73:562-70. 2009
    ..To assess the conformity of dynamic conformal arc linear accelerator-based stereotactic radiosurgery and to describe a standardized method of isodose surface (IDS) selection...
  16. ncbi Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target
    Randy L Jensen
    Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Building 550, Fifth Floor, 175 North Medical Drive, Salt Lake City, UT 84132, USA
    J Neurooncol 92:317-35. 2009
    ..An understanding of the role of hypoxia in tumor development and growth is important for physicians involved in the care of patients with brain tumors...
  17. ncbi Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis
    Brian T Ragel
    Department of Neurosurgery, University of Utah, Salt Lake City, UT 84132, USA
    Neurosurg Rev 30:181-7; discussion 187. 2007
    ..Future studies will focus on the hypothesis that Depp is up-regulated in an autocrine fashion by the AKR1C3 enzyme in U-251 glioma cells under hypoxic conditions...
  18. ncbi Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures
    Randy L Jensen
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132, USA
    Neurosurg Focus 20:E24. 2006
    ..In this model, intratumoral hypoxia causes genetic changes that produce a microenvironment that selects for cells of a more aggressive phenotype...
  19. ncbi Development of contrast enhancement after long-term observation of a dysembryoplastic neuroepithelial tumor
    Randy L Jensen
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132 2303, USA
    J Neurooncol 78:59-62. 2006
    ..This case demonstrates the potential that DNETs may exhibit a changing MRI pattern over time. Natural history, imaging characteristics, and management are reviewed...
  20. ncbi Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas
    Randy L Jensen
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132 2303, USA
    J Neurooncol 78:233-47. 2006
    ..We examined the effect of HIF-1alpha on VEGF secretion, tumor growth, and angiogenesis in malignant gliomas...
  21. ncbi Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance
    Dennis C Shrieve
    Department of Radiation Oncology, The Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    J Neurosurg 101:390-5. 2004
    ..An analysis of the expected efficacy of hypofractionation compared with the estimated optic tolerance to fractionated radiotherapy was undertaken...
  22. ncbi Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas
    Randy L Jensen
    Department of Neurosurgery, University of Utah, Salt Lake City 84132 2303, USA
    J Neurosurg 97:658-67. 2002
    ..In this study, the authors examine the expression of HIF-1alpha and VEGF in meningiomas, with a special emphasis on conditions of hypoxia, such as preoperative embolization, and on in vitro studies in cultured cells...
  23. ncbi Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression
    Randy L Jensen
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132 2303, USA
    J Neurosurg 100:488-97. 2004
    ..In this study the authors examine the role of VHL and HIF-1 in ELS tumors...
  24. ncbi Role of stereotactic radiosurgery in the treatment of brain metastases
    Lisa J Hazard
    Department of Radiation Oncology, Huntsman Cancer Hospital, Salt Lake City, Utah 84112, USA
    Am J Clin Oncol 28:403-10. 2005
    ..The authors review the role of SRS in the treatment of brain metastases and discuss the use of SRS with or without whole-brain radiation therapy, optimal dose of SRS, SRS delivery methods, and selection of appropriate patients for SRS...
  25. ncbi A comparison of the cell lines used in meningioma research
    Brian T Ragel
    Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Surg Neurol 70:295-307; discussion 307. 2008
    ..We address 2 criticisms of the mouse xenograft flank tumor model: Why are tumor induction rates derived from operative specimens low and inconsistent? Are flank tumors meningiomas?..
  26. ncbi Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application
    Brian T Ragel
    Department of Neurosurgery, University of Utah; and Huntsman Cancer Institute, Salt Lake City, Utah 84132, USA
    J Neurosurg 103:508-17. 2005
    ..Celecoxib inhibits meningioma growth in vitro in a dose-dependent fashion, with evidence of apoptosis. Inhibitors of COX-2 may have a role in the treatment of recurrent meningiomas...
  27. ncbi New approaches for the treatment of refractory meningiomas
    Brian Ragel
    Department of Neurosurgery, University of Utah, Salt Lake City 84132, USA
    Cancer Control 10:148-58. 2003
  28. ncbi Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas
    Brian T Ragel
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132, USA
    Neurosurg Focus 23:E10. 2007
    ..The use of CCAs is attractive as an adjunct treatment for unresectable or recurrent meningiomas because they are safe drugs with well-known side effect profiles that lend themselves to long-term chronic therapy...
  29. ncbi Pleomorphic liposarcoma originating from intracranial dura mater
    Michael L Mumert
    Department of Neurosurgery, University of Utah, Salt Lake City, UT, USA
    J Neurooncol 97:149-53. 2010
    ..The authors review the few cases of primary or metastatic pleomorphic liposarcoma that have been reported involving the head...
  30. ncbi Variations of disseminated choroid plexus papilloma: 2 case reports and a review of the literature
    Todd McCall
    Department of Neurosurgery, University of Utah, Salt Lake City, UT 84132, USA
    Surg Neurol 66:62-7; discussion 67-8. 2006
    ..The prognosis for patients with disseminated choroid plexus papilloma can range from prolonged stable disease and symptoms to death within months...
  31. ncbi Hypophysial transposition (hypophysopexy) for radiosurgical treatment of pituitary tumors involving the cavernous sinus. Technical note
    James K Liu
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132-2303, USA
    Neurosurg Focus 14:e11. 2003
    ..The increased distance between the normal pituitary gland and the residual tumor facilitates treatment of the tumor with radiosurgery and reduces radiation exposure to the normal pituitary gland...
  32. ncbi Surgical strategies for recurrent craniofacial meningiomas
    Ganesh Rao
    Department of Neurosurgery, University of Utah, Salt Lake City 84132, USA
    Neurosurgery 58:874-80; discussion 874-80. 2006
    ..Although combined approaches may be necessary to achieve a gross total resection, these lesions can often be reached using standard transcranial techniques...
  33. ncbi A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation
    Brian T Ragel
    Department of Neurosurgery, University of Utah, Salt Lake City 84132, USA
    J Neurosurg 108:304-10. 2008
    ..The authors describe a mouse model of intracranial meningioma that uses this novel BLI system...
  34. ncbi Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors
    Lester J Layfield
    Department of Pathology, University of Utah Hospital and Clinics, Salt Lake City, Utah 84132, USA
    Appl Immunohistochem Mol Morphol 14:91-6. 2006
    ..p53 expression was also determined by immunohistochemistry and correlated with the other variables and survival...
  35. ncbi Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors
    Brian T Ragel
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 94132, USA
    Neurosurg Focus 23:E7. 2007
    ..In addition, celecoxib is well tolerated in humans, making its use as a chronic therapy for meningiomas attractive...
  36. ncbi Molecular genetics of meningiomas
    Brian T Ragel
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132, USA
    Neurosurg Focus 19:E9. 2005
    ..Ultimately, a better understanding of the molecular pathways of meningioma tumorigenesis will lead to new, successful treatments...
  37. ncbi Primary spinal yolk sac tumor with brain metastasis: case report and review of the literature
    Peter Kan
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132, USA
    J Neurooncol 78:249-53. 2006
    ..The authors review the available literature on the treatment of intracranial malignant germ cell tumors, extrapolated to apply to the much rarer spinal lesions...
  38. ncbi WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options
    Toba N Niazi
    Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84132, USA
    J Neurooncol 91:323-8. 2009
    ..All patients require initial close serial imaging and follow-up. The role of chemotherapy is still uncertain but may be necessary in younger patients who may have tumors that behave more like the pediatric ependymomas...
  39. ncbi Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article
    Edward F Chang
    Brain Tumor Research Center, Department of Neurosurgery, University of California, San Francisco, California 94143, USA
    J Neurosurg 111:203-10. 2009
    ..The objective of this study was to validate the scoring system in a large patient group drawn from multiple external institutions...
  40. ncbi Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors. Case report with histological and molecular differentiation of the tumors and review of the literature
    Peter Kan
    Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132-2303, USA
    J Neurosurg 100:700-5. 2004
    ..They review the literature on multiple primary brain tumors with different histological characteristics and discuss potential mechanisms for the development of these lesions...
  41. ncbi Multimodality management of brain metastases in metastatic melanoma patients
    Wolfram E Samlowski
    Section of Melanoma, Renal Cancer and Immunotherapy, Nevada Cancer Institute, One Breakthrough Way, 10441 W Twain Ave, Las Vegas, NV 89135, USA
    Expert Rev Anticancer Ther 7:1699-705. 2007
    ..Current data suggest that aggressive treatment of patients with up to five brain melanoma brain metastases is capable of producing prolonged survival in many patients, including some long-term complete responses...
  42. ncbi Meningioma of the jugular foramen: glomus jugulare mimic and surgical challenge
    M Erik Gilbert
    Division of Otolaryngology Head and Neck Surgery, University of Utah Health Sciences Center, Salt Lake City 84123, USA
    Laryngoscope 114:25-32. 2004
    ..There is controversy regarding the selection of surgical approach, particularly with regard to management of the facial nerve. A reliable means of accurate preoperative diagnosis would help surgical planning and patient counseling...
  43. ncbi Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms
    Yuan Rong
    Department of Pathology and Laboratory Medicine, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Cancer Res 66:7067-74. 2006
    ..We conclude that hypoxic up-regulation of tissue factor in glioblastoma multiforme cells depends largely on Egr-1 and is independent of HIF-1...
  44. ncbi Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients
    Sunil J Patel
    Department of Neurological Surgery, Medical University of South Carolina, Charleston, South Carolina, USA
    Neurosurgery 56:1243-52; discussion 1252-3. 2005
    ..This method of administration has an acceptable safety profile compared with literature reports of other therapeutics delivered by convection-enhanced delivery...
  45. ncbi Intracerebral amyloidoma can mimic high-grade glioma on magnetic resonance imaging and spectroscopy
    Brian T Ragel
    Arch Neurol 63:906-7. 2006